跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (100 MEQ/L) - HSA Drug Approval Details
Approvals
/
HSA
/
POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (100 MEQ/L)
Approved
THERAPEUTIC
POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (100 MEQ/L)
BAXTER HEALTHCARE CORPORATION (UNITED STATES)
🇸🇬 Health Sciences Authority
Approval Date
May 29, 2001
Approval ID
4d2d87acffba390c
Company
BAXTER HEALTHCARE CORPORATION (UNITED STATES)
Type
Therapeutic
Approval Details
Approval Id
4d2d87acffba390c
Drug Name
POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (100 MEQ/L)
Product Name
POTASSIUM CHLORIDE INJECTION - HIGHLY CONCENTRATED (100 MEQ/L)
Approval Number
SIN11532P
Approval Date
2001-05-29
Registrant
BAXTER HEALTHCARE (ASIA) PTE LTD
Licence Holder
BAXTER HEALTHCARE (ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS
Atc Code
B05BB01
Atc Item Name
electrolytes
Pharma Manufacturer Name
BAXTER HEALTHCARE (ASIA) PTE LTD
Active Ingredients
POTASSIUM CHLORIDE
746 mg/100 ml
POTASSIUM CHLORIDE
746 MG/100 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 29, 2001
Approval ID
4d2d87acffba390c
Type
Therapeutic
Back to HSA Approvals